Levagen+ Palmitoylethanolamide (PEA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Levagen+ Palmitoylethanolamide (PEA), covering 2024-05-13 to 2024-05-13. Get the full timeline:
Most recent: Clinical Trial Update: Impact of Levagen+® Palmitoylethanolamide (PEA) in a Cross-Over Trial Examining Stress and Cognition in University Students [NA]